Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area
Microbial Drug Resistance · 2023
DOI: 10.1089/mdr.2022.0348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, 2023. Verfasst von Rana Elshimy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Egyptian Drug Authority, Giza, Egypt. Hauptthemen laut MEDLINE: Shiga-Toxigenic Escherichia coli, Escherichia coli Proteins, Escherichia coli Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Background
Shiga toxin-producing Escherichia coli (STEC) has been identified as an important etiologic agent of human disease in Egypt.
Aims
To investigate the occurrence and describe the characterization as well as prevalence of STEC in Greater Cairo hospitals as well as molecular characterization of virulence and resistance genes.
Methods
Four hundred seventy E. coli clinical isolates were collected from eight hospitals and analyzed by genotypic and phenotypic methods for STEC, followed by histopathological examination and scoring of different organs lesions.
Results
The highest proportion of isolates was from urine (151 isolates), whereas the lowest was from splenic drain (3 isolates). In tandem, when serogrouping was performed, 15 serogroups were obtained where the most prevalent was O157 and the least prevalent was O151. All isolates were positive when screened for identity gene gad A, while only typable strains were screened for seven virulence genes stx 1 (gene encoding Shiga toxin 1), stx 2 (gene encoding Shiga toxin 2), tsh (gene encoding thermostable hemagglutinin), eae A (gene encoding intimin), invE (gene encoding invasion protein), aggR (gene encoding aggregative adherence transcriptional regulator), and ast A (aspartate transaminase) where the prevalence was 48%, 30%, 50%, 57%, 7.5%, 12%, and 58%, respectively. Of 254 typable isolates, 152 were STEC carrying stx 1 or stx 2 genes or both.
Conclusions
Relying on in vivo comparison between different E. coli pathotypes via histopathological examination of different organs, E. coli pathotypes could be divided into mild virulent, moderate virulent, and high virulent strains. Statistical analysis revealed significant correlation between different serogroups and presence of virulence genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Egyptian Drug Authority, Giza, Egypt.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Egypt.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Zitieren
APA
Elshimy, R., Zedan, H., Elmorsy, T. H., & Khattab, R. A. (2023). Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2022.0348
Vancouver
Elshimy R, Zedan H, Elmorsy TH, Khattab RA. Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area. Microbial Drug Resistance. 2023. doi:10.1089/mdr.2022.0348
BibTeX
@article{Elshimy2023,
author = {Elshimy, Rana and Zedan, Hamdallah and Elmorsy, Tarek H and Khattab, Rania Abdelmonem},
title = {Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area},
journal = {Microbial Drug Resistance},
year = {2023},
doi = {10.1089/mdr.2022.0348}
}
EUVIMED